Core Healthcare Ltd Stock Analysis

BSE: 500091 | NSE: COREPARENT | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - Make an Informed Decision on Core Healthcare

M-Cap below 100cr DeciZen not available

FAQ's

1. Is Core Healthcare Ltd. a good quality company?

Data is not available for this company.

2. Is Core Healthcare Ltd. undervalued or overvalued?

No data found

3. Is Core Healthcare Ltd. a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Core Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Core Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
Jun'98Jun'99Jun'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07TTM
ROCE % -2.7%-4.9%-15.7%-8%-3.4%-5%-7.2%-6.9%-7.5%3.2%-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 2543021581391231611181024900
YoY Gr. Rt. %-18.8%-47.7%-12%-11.4%30.4%-26.2%-14.3%-51.8%-100%-
Adj EPS -26.8-37.9-79-65.3-36.2-36.4-41.9-39.9-18.13.713.2
YoY Gr. Rt. %-NANANANANANANANANA-
BVPS (₹) 45.5-11.2-120-238.9-216.5-249.9-299.5-348.7-367.8-42.2-351.1
Adj Net Profit -95.8-136-283-234-130-130-150-143-64.913.447
Cash Flow from Ops. -57.6-98.3-134-189-84.8-48.3-111-96.5-3.2-5.1-
Debt/CF from Ops. -16.8-11.1-9.5-10.2-18.1-33.4-15.6-19.1-575.1-29.7-

CAGR

CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales -100%-100%-100%-100%
Adj EPS NANANANA
BVPS -199.2000
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide
Jun'98Jun'99Jun'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07TTM
Return on Equity % -44.7-94.928849.225.621.120.216.16.5-2.3-6.7
Op. Profit Mgn % 138.5-36.4-6.93.85.612.13.9-44.200
Net Profit Mgn % -37.7-45-179-168.2-105.4-81.3-126.5-140.5-132.500
Debt to Equity 6.3-28.8-3.1-2.4-2.1-1.9-1.7-1.6-1.5-1.1-
Working Cap Days 027235427119816022323642100
Cash Conv. Cycle 06693-8-160-5-11-300

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Core Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) 13.2 -18
TTM Sales (₹ Cr.) 0 49
BVPS (₹.) -351.1 -364.7
Reserves (₹ Cr.) -1,069 -1,113
P/BV -0.02 -0.02
PE 0.52 0.00
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) 3.12 / 460.00
Market Cap (₹ Cr.) 24.6
Equity (₹ Cr.) 35.8
Face Value (₹) 10
Industry PE 39.1

Management X-Ray of Core Healthcare :

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Analyst's Notes

News

About Core Healthcare Ltd

Core Healthcare (CHL) was incorporated in the year 1985 and was founded by Sushil Handa and Sunil Handa, as a fluids company with a capacity of 6 million units per year and an investment of Rs 4.5 crore.

In 1988, it tapped the capital markets with an IPO of Rs 36 lakh and a second offering of Rs 19 crore partly convertible debentures in 1992 to fund its expansion plans. It also issued global depository receipts (GDRs) of around Rs 80 crore in 1994 at the Luxemburg Stock Exchange.

The company is into manufacture and distribution of intravenous solutions, injectibles, medical disposables and tablets.

ARCIL a securitisation and reconstruction company acquired 60% (Rs 380 crore) of CHL's total borrowing of Rs 650 crore in 2003.

In the year 2004, almost eight years after it landed in debt, CHL finally found a buyer for its intravenous (IV) fluids and medical devices business in Nirma Limited.  The deal for the sale of CHL's assets and liabilities was wrapped up with a Memorandum of Understanding (MoU) being signed between Nirma and the Asset Reconstruction Company (India) Ltd (ARCIL)

In the scheme of arrangement of the demerger of Core Healthcare with Nirma Ltd, the company made a compromise and arrangement with its lenders with effect from the Appointed Date for Reconstruction i.e., November 30, 2004. This was  in consideration for the transfer of and vesting of the assets and liabilities of demerged undertaking of the company into Nirma, one equity share of Re 1 each of Nirma were issued for 16 equity shares of Rs 10 each fully paid up held in CHL.

The company’s pharmaceutical possession, which was taken over by ARCIL in July 2005, had issued a notice for sale of assets of this plant by March 2007.

The company was ordered to wind up its business on June 24, 2009.

In 2012 CORE Health Care recognized as one of the Top Workplaces in 2012 by the Austin American Statesman.

 

Read More Read Less